Fedele P, Rizzo A, Landriscina M, Stucci LS, et al. Early first-line systemic anticancer therapeutic attrition after metastatic
recurrence in triple-negative breast cancer following neoadjuvant
chemo-immunotherapy: a multicenter real-world study. Breast Cancer Res Treat 2026;218:8.
PMID: 42430019
|